|
2024-05-02 |
2024-05-02 |
B
Purchase
|
LUDWIG EDWARD J
Non-Executive Director
|
1,000
+4.8%
53.88
100,000
USD
|
1,000
+4.8%
|
53.88
|
100,000
USD
|
|
|
2024-05-02 |
2024-05-02 |
B
Purchase
|
Mahoney Michael F
Non-Executive Director
|
1,000
+5246.3%
54.49
100,000
USD
|
1,000
+5246.3%
|
54.49
|
100,000
USD
|
|
|
2024-02-16 |
2024-02-16 |
S
Sale
|
Shah Prem S
EVP and Pres-Pharm, Consumer W
Officer
|
29,473
-42.6%
76.95
2,267,947
USD
|
29,473
-42.6%
|
76.95
|
2,267,947
USD
|
|
|
2023-11-06 |
2023-11-03 |
B
Purchase
|
LUDWIG EDWARD J
Non-Executive Director
|
2,000
+10.7%
70.47
140,930
USD
|
2,000
+10.7%
|
70.47
|
140,930
USD
|
|
|
2023-08-04 |
2023-08-03 |
S
Sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
23,128
-83.1%
74.94
1,733,212
USD
|
23,128
-83.1%
|
74.94
|
1,733,212
USD
|
|
|
2023-08-04 |
2023-08-03 |
S
Sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
2,631
-8.6%
74.79
196,792
USD
|
2,631
-8.6%
|
74.79
|
196,792
USD
|
|
|
2023-05-05 |
2023-05-03 |
B
Purchase
|
Lynch Karen S
President and CEO
Executive Director
|
14,000
+3.4%
69.75
976,567
USD
|
14,000
+3.4%
|
69.75
|
976,567
USD
|
|
|
2022-12-16 |
2022-12-15 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
36,490
-5.7%
98.24
3,584,869
USD
|
36,490
-5.7%
|
98.24
|
3,584,869
USD
|
|
|
2022-12-16 |
2022-12-15 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
100,976
-14.2%
98.40
9,936,311
USD
|
100,976
-14.2%
|
98.40
|
9,936,311
USD
|
|
|
2022-08-05 |
2022-08-04 |
PS
Planned sale
|
Lotvin Alan
EVP&President-PharmacyServices
Officer
|
22,541
-17.1%
104.00
2,344,264
USD
|
22,541
-17.1%
|
104.00
|
2,344,264
USD
|
|
|
2022-08-05 |
2022-08-03 |
PS
Planned sale
|
Lotvin Alan
EVP&President-PharmacyServices
Officer
|
50,501
-31.6%
98.00
4,949,098
USD
|
50,501
-31.6%
|
98.00
|
4,949,098
USD
|
|
|
2022-08-05 |
2022-08-03 |
PS
Planned sale
|
Lotvin Alan
EVP&President-PharmacyServices
Officer
|
70,398
-39.2%
98.00
6,899,004
USD
|
70,398
-39.2%
|
98.00
|
6,899,004
USD
|
|
|
2022-08-05 |
2022-08-03 |
PS
Planned sale
|
Finke Daniel P
EVP/Pres, Health Care Benefits
Officer
|
9,546
-22.9%
100.00
954,600
USD
|
9,546
-22.9%
|
100.00
|
954,600
USD
|
|
|
2022-04-12 |
2022-04-08 |
PS
Planned sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
3,130
-6.7%
105.00
328,650
USD
|
3,130
-6.7%
|
105.00
|
328,650
USD
|
|
|
2022-04-12 |
2022-04-08 |
PS
Planned sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
4,103
-8.1%
105.00
430,815
USD
|
4,103
-8.1%
|
105.00
|
430,815
USD
|
|
|
2022-04-12 |
2022-04-08 |
PS
Planned sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
5,719
-10.9%
105.00
600,495
USD
|
5,719
-10.9%
|
105.00
|
600,495
USD
|
|
|
2022-04-12 |
2022-04-08 |
PS
Planned sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
3,157
-6.3%
105.00
331,485
USD
|
3,157
-6.3%
|
105.00
|
331,485
USD
|
|
|
2022-04-12 |
2022-04-08 |
PS
Planned sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
845
-1.8%
105.00
88,725
USD
|
845
-1.8%
|
105.00
|
88,725
USD
|
|
|
2022-04-06 |
2022-04-05 |
PS
Planned sale
|
Finke Daniel P
EVP/Pres, Health Care Benefits
Officer
|
5,941
-15.6%
100.00
594,100
USD
|
5,941
-15.6%
|
100.00
|
594,100
USD
|
|
|
2022-04-06 |
2022-04-04 |
PS
Planned sale
|
Finke Daniel P
EVP/Pres, Health Care Benefits
Officer
|
12,032
-24.0%
100.13
1,204,764
USD
|
12,032
-24.0%
|
100.13
|
1,204,764
USD
|
|
|
2022-04-06 |
2022-04-04 |
PS
Planned sale
|
Finke Daniel P
EVP/Pres, Health Care Benefits
Officer
|
27,166
-35.1%
100.13
2,720,132
USD
|
27,166
-35.1%
|
100.13
|
2,720,132
USD
|
|
|
2022-04-06 |
2022-04-04 |
PS
Planned sale
|
Finke Daniel P
EVP/Pres, Health Care Benefits
Officer
|
16,161
-24.4%
100.13
1,618,201
USD
|
16,161
-24.4%
|
100.13
|
1,618,201
USD
|
|
|
2022-03-18 |
2022-03-17 |
S
Sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
2,935
-4.7%
106.65
313,018
USD
|
2,935
-4.7%
|
106.65
|
313,018
USD
|
|
|
2022-03-18 |
2022-03-17 |
S
Sale
|
Shah Prem S
EVP and Co-President of Retail
Officer
|
1,689
-2.8%
106.65
180,132
USD
|
1,689
-2.8%
|
106.65
|
180,132
USD
|
|
|
2022-03-17 |
2022-03-15 |
S
Sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
51,361
-5.8%
105.00
5,392,905
USD
|
51,361
-5.8%
|
105.00
|
5,392,905
USD
|
|
|
2022-02-11 |
2022-02-10 |
B
Purchase
|
LUDWIG EDWARD J
Non-Executive Director
|
1,000
+5.8%
105.90
105,904
USD
|
1,000
+5.8%
|
105.90
|
105,904
USD
|
|
|
2022-02-04 |
2022-02-03 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
47,937
-25.7%
110.00
5,273,070
USD
|
47,937
-25.7%
|
110.00
|
5,273,070
USD
|
|
|
2022-02-02 |
2022-02-01 |
PS
Planned sale
|
Lotvin Alan
EVP&President-PharmacyServices
Officer
|
21,386
-25.9%
106.50
2,277,566
USD
|
21,386
-25.9%
|
106.50
|
2,277,566
USD
|
|
|
2022-02-01 |
2022-01-28 |
PS
Planned sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
6,059
-25.7%
109.00
660,431
USD
|
6,059
-25.7%
|
109.00
|
660,431
USD
|
|
|
2022-01-28 |
2022-01-27 |
PS
Planned sale
|
Roberts Jonathan C
EVP & Chief Operating Officer
Officer
|
68,482
-39.0%
107.50
7,361,815
USD
|
68,482
-39.0%
|
107.50
|
7,361,815
USD
|
|
|
2021-11-05 |
2021-11-03 |
PS
Planned sale
|
Roberts Jonathan C
EVP & Chief Operating Officer
Officer
|
108,870
-50.4%
95.00
10,342,650
USD
|
108,870
-50.4%
|
95.00
|
10,342,650
USD
|
|
|
2021-11-03 |
2021-11-01 |
S
Sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
28,159
-16.9%
90.00
2,534,310
USD
|
28,159
-16.9%
|
90.00
|
2,534,310
USD
|
|
|
2021-10-28 |
2021-10-26 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
80,802
-36.9%
88.00
7,110,576
USD
|
80,802
-36.9%
|
88.00
|
7,110,576
USD
|
|
|
2021-10-28 |
2021-10-26 |
S
Sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
1,955
-0.9%
88.00
172,040
USD
|
1,955
-0.9%
|
88.00
|
172,040
USD
|
|
|
2021-06-29 |
2021-06-28 |
PS
Planned sale
|
Lotvin Alan
EVP&President-PharmacyServices
Officer
|
2,781
-4.4%
83.67
232,686
USD
|
2,781
-4.4%
|
83.67
|
232,686
USD
|
|
|
2021-06-17 |
2021-06-15 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
67,552
-32.1%
86.00
5,809,472
USD
|
67,552
-32.1%
|
86.00
|
5,809,472
USD
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
Finke Daniel P
EVP/Pres, Health Care Benefits
Officer
|
37,594
-61.7%
86.60
3,255,640
USD
|
37,594
-61.7%
|
86.60
|
3,255,640
USD
|
|
|
2021-05-12 |
2021-05-10 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
109,469
-100.0%
86.00
9,414,334
USD
|
109,469
-100.0%
|
86.00
|
9,414,334
USD
|
|
|
2021-05-10 |
2021-05-07 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
9,477
-6.1%
84.00
796,068
USD
|
9,477
-6.1%
|
84.00
|
796,068
USD
|
|
|
2021-05-06 |
2021-05-04 |
PS
Planned sale
|
Boratto Eva C
EVP & CFO
Officer
|
4,905
-4.1%
80.00
392,400
USD
|
4,905
-4.1%
|
80.00
|
392,400
USD
|
|
|
2021-04-23 |
2021-04-21 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
2,420
-100.0%
77.00
186,340
USD
|
2,420
-100.0%
|
77.00
|
186,340
USD
|
|
|
2021-04-23 |
2021-04-21 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
101,003
-97.7%
77.00
7,777,231
USD
|
101,003
-97.7%
|
77.00
|
7,777,231
USD
|
|
|
2021-04-01 |
2021-03-31 |
PS
Planned sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
5,350
-42.5%
76.00
406,600
USD
|
5,350
-42.5%
|
76.00
|
406,600
USD
|
|
|
2021-03-30 |
2021-03-29 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
62,943
-100.0%
76.15
4,793,109
USD
|
62,943
-100.0%
|
76.15
|
4,793,109
USD
|
|
|
2021-03-29 |
2021-03-26 |
PS
Planned sale
|
MERLO LARRY J
Non-Executive Director
|
270,650
-34.1%
74.73
20,225,675
USD
|
270,650
-34.1%
|
74.73
|
20,225,675
USD
|
|
|
2021-03-29 |
2021-03-26 |
PS
Planned sale
|
Roberts Jonathan C
EVP & Chief Operating Officer
Officer
|
73,433
-99.1%
74.49
5,470,024
USD
|
73,433
-99.1%
|
74.49
|
5,470,024
USD
|
|
|
2021-03-23 |
2021-03-19 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
Officer
|
49,211
-73.0%
74.15
3,648,996
USD
|
49,211
-73.0%
|
74.15
|
3,648,996
USD
|
|
|
2021-03-17 |
2021-03-16 |
PS
Planned sale
|
Boratto Eva C
EVP & CFO
Officer
|
18,882
-21.0%
74.68
1,410,108
USD
|
18,882
-21.0%
|
74.68
|
1,410,108
USD
|
|
|
2021-02-17 |
2021-02-17 |
B
Purchase
|
LUDWIG EDWARD J
Non-Executive Director
|
3,000
+26.5%
72.00
216,000
USD
|
3,000
+26.5%
|
72.00
|
216,000
USD
|
|
|
2021-01-21 |
2021-01-19 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
62,893
-10.7%
77.00
4,842,761
USD
|
62,893
-10.7%
|
77.00
|
4,842,761
USD
|
|
|
2021-01-13 |
2021-01-12 |
PS
Planned sale
|
Bisaccia Lisa
EVP and Chief HR Officer
Officer
|
25,177
-35.1%
77.00
1,938,629
USD
|
25,177
-35.1%
|
77.00
|
1,938,629
USD
|
|
|
2021-01-12 |
2021-01-08 |
PS
Planned sale
|
Lotvin Alan
EVP and President-CVS Caremark
Officer
|
25,836
-75.5%
75.00
1,937,700
USD
|
25,836
-75.5%
|
75.00
|
1,937,700
USD
|
|
|
2021-01-12 |
2021-01-08 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
58,896
-56.1%
75.00
4,417,200
USD
|
58,896
-56.1%
|
75.00
|
4,417,200
USD
|
|
|
2020-11-17 |
2020-11-13 |
PS
Planned sale
|
Lotvin Alan
EVP and President-CVS Caremark
Officer
|
7,138
-47.1%
70.00
499,660
USD
|
7,138
-47.1%
|
70.00
|
499,660
USD
|
|
|
2020-11-12 |
2020-11-10 |
PS
Planned sale
|
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL
Officer
|
21,460
-46.2%
70.00
1,502,200
USD
|
21,460
-46.2%
|
70.00
|
1,502,200
USD
|
|
|
2020-05-28 |
2020-05-26 |
PS
Planned sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
270
-5.6%
65.00
17,550
USD
|
270
-5.6%
|
65.00
|
17,550
USD
|
|
|
2020-05-28 |
2020-05-26 |
PS
Planned sale
|
Mayhew Jonathan E.
EVP - Transformation
Officer
|
10,556
-69.0%
65.00
686,140
USD
|
10,556
-69.0%
|
65.00
|
686,140
USD
|
|
|
2020-05-13 |
2020-05-11 |
B
Purchase
|
Lotvin Alan
EVP and President-CVS Caremark
Officer
|
5,000
+49.2%
63.14
315,675
USD
|
5,000
+49.2%
|
63.14
|
315,675
USD
|
|
|
2020-04-30 |
2020-04-28 |
PS
Planned sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
6,234
-56.4%
65.00
405,210
USD
|
6,234
-56.4%
|
65.00
|
405,210
USD
|
|
|
2020-04-01 |
2020-03-30 |
PS
Planned sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
3,030
-23.7%
60.00
181,800
USD
|
3,030
-23.7%
|
60.00
|
181,800
USD
|
|
|
2020-01-17 |
2020-01-15 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
266,476
-37.9%
74.79
19,929,740
USD
|
266,476
-37.9%
|
74.79
|
19,929,740
USD
|
|
|
2020-01-10 |
2020-01-08 |
PS
Planned sale
|
Roberts Jonathan C
EVP & Chief Operating Officer
|
57,563
-56.1%
72.63
4,180,801
USD
|
57,563
-56.1%
|
72.63
|
4,180,801
USD
|
|
|
2019-11-20 |
2019-11-18 |
PS
Planned sale
|
Lynch Karen S
EVP & Pres, Aetna Bus Unit
|
80,143
-65.7%
75.00
6,010,725
USD
|
80,143
-65.7%
|
75.00
|
6,010,725
USD
|
|
|
2019-11-06 |
2019-11-04 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
23,604
-21.9%
68.00
1,605,072
USD
|
23,604
-21.9%
|
68.00
|
1,605,072
USD
|
|
|
2019-10-01 |
2019-09-30 |
PS
Planned sale
|
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL
|
17,703
-49.0%
63.00
1,115,289
USD
|
17,703
-49.0%
|
63.00
|
1,115,289
USD
|
|
|
2019-09-13 |
2019-09-12 |
PS
Planned sale
|
Boratto Eva C
EVP & CFO
|
8,130
-14.7%
65.00
528,450
USD
|
8,130
-14.7%
|
65.00
|
528,450
USD
|
|
|
2019-03-11 |
2019-03-11 |
B
Purchase
|
BROWN C DAVID II
|
10,000
+9.9%
53.18
531,800
USD
|
10,000
+9.9%
|
53.18
|
531,800
USD
|
|
|
2019-03-11 |
2019-03-11 |
B
Purchase
|
AGUIRRE FERNANDO
|
1,900
+13.3%
53.59
101,821
USD
|
1,900
+13.3%
|
53.59
|
101,821
USD
|
|
|
2019-03-11 |
2019-03-08 |
B
Purchase
|
LUDWIG EDWARD J
|
2,000
+37.2%
52.80
105,600
USD
|
2,000
+37.2%
|
52.80
|
105,600
USD
|
|
|
2019-03-11 |
2019-03-08 |
B
Purchase
|
DORMAN DAVID W
Non-Executive Director
|
9,600
+8.5%
52.71
506,016
USD
|
9,600
+8.5%
|
52.71
|
506,016
USD
|
|
|
2019-03-04 |
2019-03-01 |
B
Purchase
|
AGUIRRE FERNANDO
|
3,410
+31.2%
58.29
198,769
USD
|
3,410
+31.2%
|
58.29
|
198,769
USD
|
|
|
2019-03-04 |
2019-03-01 |
B
Purchase
|
LUDWIG EDWARD J
|
4,000
+290.3%
58.27
233,080
USD
|
4,000
+290.3%
|
58.27
|
233,080
USD
|
|
|
2019-03-01 |
2019-03-01 |
S
Sale
|
Clark James David
SVP, Cont & Chief Acct Officer
Officer
|
1,664
-19.4%
58.14
96,745
USD
|
1,664
-19.4%
|
58.14
|
96,745
USD
|
|
|
2019-02-04 |
2019-02-01 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
166,368
-33.5%
64.51
10,732,400
USD
|
166,368
-33.5%
|
64.51
|
10,732,400
USD
|
|
|
2019-02-04 |
2019-02-01 |
PS
Planned sale
|
Roberts Jonathan C
EVP & Chief Operating Officer
Officer
|
77,639
-69.7%
64.54
5,010,821
USD
|
77,639
-69.7%
|
64.54
|
5,010,821
USD
|
|
